{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:56:14Z","timestamp":1792162574077,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Berlin Institute of Health"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.taap.2016.12.003","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T17:48:20Z","timestamp":1481046500000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Clozapine-induced agranulocytosis: Evidence for an immune-mediated mechanism from a patient-specific in-vitro approach"],"prefix":"10.1016","volume":"316","author":[{"given":"Francesca","family":"Regen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmelin","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ruehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Le Bret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dettling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hellmann-Regen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 12","key":"10.1016\/j.taap.2016.12.003_bb0005","first-page":"39","article-title":"Clozapine: the commitment to patient safety","volume":"60","author":"Alphs","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2016.12.003_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4088\/JCP.09m05527yel","article-title":"Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis","volume":"72","author":"Athanasiou","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0020","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","article-title":"Clozapine. A novel antipsychotic agent","volume":"324","author":"Baldessarini","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2016.12.003_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/npp.1993.50","article-title":"Tissue concentrations of clozapine and its metabolites in the rat","volume":"9","author":"Baldessarini","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.taap.2016.12.003_bb0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0010-440X(99)90134-7","article-title":"Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy","volume":"40","author":"Barak","year":"1999","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0035","first-page":"247","article-title":"Inhibitory effect of antipsychotic drugs on the Con A- and LPS-induced proliferative activity of mouse splenocytes: a possible mechanism of action","volume":"57","author":"Basta-Kaim","year":"2006","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.003_bb0040","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2307\/1591566","article-title":"Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes","volume":"36","author":"Bounous","year":"1992","journal-title":"Avian Dis."},{"key":"10.1016\/j.taap.2016.12.003_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jcla.1860090203","article-title":"Quantification of mitogen induced human lymphocyte proliferation: comparison of alamarBlue assay to 3H-thymidine incorporation assay","volume":"9","author":"de Fries","year":"1995","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.taap.2016.12.003_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajmg.b.32287","article-title":"Genome-wide association study of lymphoblast cell viability after clozapine exposure","volume":"168B","author":"de With","year":"2015","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.taap.2016.12.003_bb0055","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4049\/jimmunol.114.3.1065","article-title":"Rabbit lymphocyte populations responding to haptenic and carrier determinants for DNA synthesis","volume":"114","author":"Delespesse","year":"1975","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2016.12.003_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/eb-2014-101813","article-title":"Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective","volume":"17","author":"Dold","year":"2014","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.taap.2016.12.003_bb0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1039856213491990","article-title":"Clozapine and agranulocytosis: re-assessing the risks","volume":"21","author":"Drew","year":"2013","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-1759(99)00082-4","article-title":"Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease Progression","volume":"227","author":"Froebel","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.taap.2016.12.003_bb0075","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/ncomms5757","article-title":"Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles","volume":"5","author":"Goldstein","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2016.12.003_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-483X(98)00110-3","article-title":"Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis","volume":"131","author":"Guest","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2016.12.003_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0095","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1176\/ajp.153.6.840a","article-title":"Clozapine-induced parotitis: an immunological cause?","volume":"153","author":"Hinze-Selch","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0893-133X(98)00006-2","article-title":"Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients","volume":"19","author":"Hinze-Selch","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.taap.2016.12.003_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11481-011-9309-0","article-title":"Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation","volume":"7","author":"Hu","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.taap.2016.12.003_bb0110","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/tx400124m","article-title":"beta-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis","volume":"26","author":"Jenkins","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2016.12.003_bb0115","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2016.12.003_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM200107193450317","article-title":"Myocarditis and cardiomyopathy associated with clozapine use in the United States","volume":"345","author":"La Grenade","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2016.12.003_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0162-3109(97)00037-4","article-title":"Short and long-term immunosuppressive effects of clozapine and haloperidol","volume":"37","author":"Leykin","year":"1997","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.taap.2016.12.003_bb0130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archpsyc.1990.01810220061007","article-title":"HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia","volume":"47","author":"Lieberman","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/cyto.a.22623","article-title":"Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data","author":"Lin","year":"2015","journal-title":"Cytometry A."},{"key":"10.1016\/j.taap.2016.12.003_bb0140","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0022-3565(25)12207-6","article-title":"Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells","volume":"275","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2016.12.003_bb0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hup.1181","article-title":"Haematological toxicity of clozapine and some other drugs used in psychiatry","volume":"26","author":"Nooijen","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.taap.2016.12.003_bb0155","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1038\/srep08502","article-title":"Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice","volume":"5","author":"Park","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2016.12.003_bb0160","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1176\/appi.ajp.162.8.1543","article-title":"Clozapine-induced allergic vasculitis","volume":"162","author":"Penaskovic","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0165","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bcp.2006.06.006","article-title":"Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis","volume":"72","author":"Pereira","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.003_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00023210-199707020-00005","article-title":"Mechanism of clozapine-induced agranulocytosis: current status of research and implications for drug development","volume":"7","author":"Pirmohamed","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.taap.2016.12.003_bb0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4939-0345-0_12","article-title":"Fast monocyte-derived dendritic cell-based immunotherapy","volume":"1139","author":"Ramadan","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.taap.2016.12.003_bb0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0006-3223(91)90147-E","article-title":"The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness","volume":"29","author":"Rapaport","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","article-title":"Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine","volume":"151","author":"Ribeiro","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.taap.2016.12.003_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/ajp.152.2.297","article-title":"Possible association of parotitis with clozapine","volume":"152","author":"Robinson","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.taap.2016.12.003_bb0195","first-page":"91","article-title":"Protein tyrosine kinase inhibition and cell proliferation: is the [3H]-thymidine uptake assay representative of the T-lymphocyte proliferation rate?","volume":"5","author":"Spinozzi","year":"1995","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.taap.2016.12.003_bb0200","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0009-9236(99)70072-X","article-title":"The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis","volume":"65","author":"Tschen","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2016.12.003_bb0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-2797(97)00017-3","article-title":"Structural features associated with reactive metabolite formation in clozapine analogues","volume":"104","author":"Uetrecht","year":"1997","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2016.12.003_bb0210","doi-asserted-by":"crossref","first-page":"703218","DOI":"10.1155\/2015\/703218","article-title":"Clozapine-induced late agranulocytosis and severe neutropenia complicated with streptococcus pneumonia, venous thromboembolism, and allergic vasculitis in treatment-resistant female psychosis","volume":"2015","author":"Voulgari","year":"2015","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.taap.2016.12.003_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-2427(99)00041-0","article-title":"Evaluation of canine lymphocyte proliferation: comparison of three different colorimetric methods with the 3H-thymidine incorporation assay","volume":"70","author":"Wagner","year":"1999","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.taap.2016.12.003_bb0220","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0022-3565(24)37177-0","article-title":"Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis","volume":"283","author":"Williams","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2016.12.003_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/mol.58.1.207","article-title":"Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine","volume":"58","author":"Williams","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.003_bb0230","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.intimp.2013.01.009","article-title":"Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL","volume":"15","author":"Wolfraim","year":"2013","journal-title":"Int. Immunopharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16303751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16303751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:09:32Z","timestamp":1749794972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X16303751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":46,"alternative-id":["S0041008X16303751"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2016.12.003","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine-induced agranulocytosis: Evidence for an immune-mediated mechanism from a patient-specific in-vitro approach","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}